BDX Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 5.84% compared to Becton Dickinson &'s net margin of 14.45%. Becton Dickinson &'s return on equity of 5.86% beat Boston Scientific's return on equity of 9.57%.

Becton Dickinson & has a consensus price target of $221.75, signalling upside risk potential of 28.77%. On the other hand Boston Scientific has an analysts' consensus of $117.02 which suggests that it could grow by 17.33%. Given that Becton Dickinson & has higher upside potential than Boston Scientific, analysts believe Becton Dickinson & is more attractive than Boston Scientific.

Becton Dickinson & has a beta of 0.251, which suggesting that the stock is 74.889% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.681, suggesting its less volatile than the S&P 500 by 31.908%.

Becton Dickinson & has a quarterly dividend of $1.04 per share corresponding to a yield of 2.36%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Becton Dickinson & pays 64.52% of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Becton Dickinson & quarterly revenues are $5.3B, which are larger than Boston Scientific quarterly revenues of $4.7B. Becton Dickinson &'s net income of $308M is lower than Boston Scientific's net income of $674M. Notably, Becton Dickinson &'s price-to-earnings ratio is 32.86x while Boston Scientific's PE ratio is 72.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Becton Dickinson & is 2.39x versus 8.46x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical has a net margin of 5.84% compared to Becton Dickinson &'s net margin of 30.99%. Becton Dickinson &'s return on equity of 5.86% beat Intuitive Surgical's return on equity of 15.82%.

Becton Dickinson & has a consensus price target of $221.75, signalling upside risk potential of 28.77%. On the other hand Intuitive Surgical has an analysts' consensus of $575.49 which suggests that it could grow by 12.36%. Given that Becton Dickinson & has higher upside potential than Intuitive Surgical, analysts believe Becton Dickinson & is more attractive than Intuitive Surgical.

Becton Dickinson & has a beta of 0.251, which suggesting that the stock is 74.889% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.875%.

Becton Dickinson & has a quarterly dividend of $1.04 per share corresponding to a yield of 2.36%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Becton Dickinson & pays 64.52% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Becton Dickinson & quarterly revenues are $5.3B, which are larger than Intuitive Surgical quarterly revenues of $2.3B. Becton Dickinson &'s net income of $308M is lower than Intuitive Surgical's net income of $698.4M. Notably, Becton Dickinson &'s price-to-earnings ratio is 32.86x while Intuitive Surgical's PE ratio is 75.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Becton Dickinson & is 2.39x versus 21.34x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

Integer Holdings has a net margin of 5.84% compared to Becton Dickinson &'s net margin of -5.14%. Becton Dickinson &'s return on equity of 5.86% beat Integer Holdings's return on equity of 4.85%.

Becton Dickinson & has a consensus price target of $221.75, signalling upside risk potential of 28.77%. On the other hand Integer Holdings has an analysts' consensus of $148.75 which suggests that it could grow by 25.74%. Given that Becton Dickinson & has higher upside potential than Integer Holdings, analysts believe Becton Dickinson & is more attractive than Integer Holdings.

Becton Dickinson & has a beta of 0.251, which suggesting that the stock is 74.889% less volatile than S&P 500. In comparison Integer Holdings has a beta of 0.979, suggesting its less volatile than the S&P 500 by 2.088%.

Becton Dickinson & has a quarterly dividend of $1.04 per share corresponding to a yield of 2.36%. Integer Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Becton Dickinson & pays 64.52% of its earnings as a dividend. Integer Holdings pays out -- of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Becton Dickinson & quarterly revenues are $5.3B, which are larger than Integer Holdings quarterly revenues of $437.4M. Becton Dickinson &'s net income of $308M is higher than Integer Holdings's net income of -$22.5M. Notably, Becton Dickinson &'s price-to-earnings ratio is 32.86x while Integer Holdings's PE ratio is 56.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Becton Dickinson & is 2.39x versus 2.39x for Integer Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Insulet has a net margin of 5.84% compared to Becton Dickinson &'s net margin of 6.22%. Becton Dickinson &'s return on equity of 5.86% beat Insulet's return on equity of 36.9%.

Becton Dickinson & has a consensus price target of $221.75, signalling upside risk potential of 28.77%. On the other hand Insulet has an analysts' consensus of $334.74 which suggests that it could grow by 9.89%. Given that Becton Dickinson & has higher upside potential than Insulet, analysts believe Becton Dickinson & is more attractive than Insulet.

Becton Dickinson & has a beta of 0.251, which suggesting that the stock is 74.889% less volatile than S&P 500. In comparison Insulet has a beta of 1.375, suggesting its more volatile than the S&P 500 by 37.475%.

Becton Dickinson & has a quarterly dividend of $1.04 per share corresponding to a yield of 2.36%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Becton Dickinson & pays 64.52% of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Becton Dickinson & quarterly revenues are $5.3B, which are larger than Insulet quarterly revenues of $569M. Becton Dickinson &'s net income of $308M is higher than Insulet's net income of $35.4M. Notably, Becton Dickinson &'s price-to-earnings ratio is 32.86x while Insulet's PE ratio is 54.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Becton Dickinson & is 2.39x versus 10.25x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.